Peter Ueda

Current positions

Assistant professor, Karolinska Institutet
Resident physician (ST-läkare), Center for Diabetes, Region Stockholm
Affiliated researcher, University of Tokyo

Education/previous positions

Docent in epidemiology, Karolinska Institutet, 2020
Intern physician (AT-läkare), Södersjukhuset, 2017-2020
Post-doctoral researcher, Harvard University, 2014-2016
PhD, Karolinska Institutet, 2014
BSc, Stockholm School of Economics (Handelshögskolan), 2012
MD, Karolinska Institutet, 2012

Main research areas include:

Safety and effectiveness of glucose-lowering drugs
We use nationwide data sources from three countries to assess safety signals of mainly GLP-1 receptor agonists and SGLT2 inhibitors (Björn Pasternak Group).

Cardiovascular risk prediction and pharmacological prevention of cardiovascular disease
We assess questions related to primary and secondary prevention of cardiovascular disease, including validation of risk scores and assessment of guideline-recommended treatment algorithms. Focus on antiplatelet therapy and cholesterol-lowering drugs.

Emerging issues in sexual health and fertility
Research program in collaboration with the University of Tokyo, with focus on young Japanese adults. Studies on the epidemiology of sexual inactivity and novel topics in sexual health research using data from national probability surveys.

Selected publications

Pasternak B, Wintzell V, Hviid A, Eliasson B, Gudbjörnsdottir S, Jonasson C, Hveem K, Svanström H, Melbye M, Ueda P. Use of Glucagon-like Peptide 1 Receptor Agonists and Risk of Thyroid Cancer. BMJ 2024

Ueda P, Pasternak B, Lim CE, Neovius M, Kader M, Forssblad M, Ludvigsson JF, Svanström H. Neurodegenerative disease among male elite football (soccer) players in Sweden: a cohort study. Lancet Public Health 2023

Ueda P, Pasternak B, Svanström H, Lim CE, Neovius M, Forssblad M, Ludvigsson JF, Kader M. Alcohol related disorders among elite male football players in Sweden: nationwide cohort study. BMJ 2022

Allahyari A, Jernberg T, Hagström E, Leosdottir M, Lundman P, Ueda P. Application of the 2019 ESC/EAS dyslipidaemia guidelines to nationwide data of patients with a recent myocardial infarction: a simulation study. European Heart Journal 2020

Pasternak B, Wintzell V, Melbye M, Eliasson B, Svensson AM, Franzén S, Gudbjörnsdottir S, Hveem K, Jonasson C, Svanström H, Ueda P. Use of sodium-glucose co-transporter 2 inhibitors and risk of serious renal events: Scandinavian cohort study. BMJ 2020

Ueda P, Mercer CH, Ghaznavi C, Herbenick D. Trends in Frequency of Sexual Activity and Number of Sexual Partners Among Adults Aged 18 to 44 Years in the US, 2000-2018. JAMA Network Open 2020

Ghaznavi C, Sakamoto H, Yoneoka D, Nomura S, Shibuya K, Ueda P. tool=karolinska">Trends in heterosexual inexperience among young adults in Japan: analysis of national surveys, 1987-2015. BMC Public Health 2019

Sakamoto H, Ishikane M, Ueda P. Seasonal Influenza Activity During the SARS-CoV-2 Outbreak in Japan. JAMA 2020

Svanström H, Ueda P, Melbye M, Eliasson B, Svensson AM, Franzén S, Gudbjörnsdottir S, Hveem K, Jonasson C, Pasternak B. Use of liraglutide and risk of major cardiovascular events: a register-based cohort study in Denmark and Sweden. Lancet Diabetes and Endocrinology 2019

Pasternak B, Ueda P, Eliasson B, Svensson AM, Franzén S, Gudbjörnsdottir S, Hveem K, Jonasson C, Wintzell V, Melbye M, Svanström H. Use of sodium glucose cotransporter 2 inhibitors and risk of major cardiovascular events and heart failure: Scandinavian register based cohort study. BMJ 2019

Ueda P, Svanström H, Melbye M, Eliasson B, Svensson AM, Franzén S, Gudbjörnsdottir S, Hveem K, Jonasson C, Pasternak B. Sodium glucose cotransporter 2 inhibitors and risk of serious adverse events: nationwide register based cohort study. BMJ 2018

Ueda P, Jernberg T, James S, Alfredsson J, Erlinge D, Omerovic E, Persson J, Ravn-Fischer A, Tornvall P, Svennblad B, Varenhorst C. External Validation of the DAPT Score in a Nationwide Population. Journal of the American College of Cardiology 2018

Ueda P, Woodward M, Lu Y, Haathalian K, Al-Wotayan R, Aguilar-Salinas CA, Ahmadvand A, Azizi F, Bentham J, Cifkova R, Di Cesare M, Eriksen L, Farzadfar F, Ferguson TS, Ikeda N, Khalili D, Khang YH, Lanska V, León-Muñoz L, Magliano DJ, Margozzini P, Msyamboza KP, Mutungi G, Oh K, Oum S, Rodríguez-Artalejo F, Rojas-Martinez R, Valdivia G, Wilks R, Shaw JE, Stevens GA, Tolstrup JS, Zhou B, Salomon JA, Ezzati M, Danaei G. Laboratory-based and office-based risk scores and charts to predict 10-year risk of cardiovascular disease in 182 countries: a pooled analysis of prospective cohorts and health surveys. Lancet Diabetes and Endocrinology 2017

Howe KB*, Suharlim C*, Ueda P*, Howe D, Kawachi I, Rimm EB. Gotta catch'em all! Pokemon GO and physical activity among young adults: difference in differences study. BMJ 2016

Hajifathalian K*, Ueda P*, Lu Y, Woodward M, Ahmadvand A, Aguilar Salinas CA, Azizi F, Cifkova R, Di Cesare M, Eriksen L, Farzadfar F, Ikeda N, Khalili D, Khang YH, Lanska V, León-Muñoz L, Magliano D, Msyamboza KP, Oh K, Rodríguez-Artalejo F, Rojas Martinez R, Shaw JE, Stevens GA, Tolstrup J, Zhou B, Salomon JA, Ezzati M, Danaei G. tool=karolinska">A novel risk score to predict cardiovascular disease risk in national populations (Globorisk): a pooled analysis of prospective cohorts and health examination surveys. Lancet Diabetes and Endocrinology 2015

Ueda P, Rafatnia F, Bäärnhielm M, Fröbom R, Korzunowicz G, Lönnerbro R, Hedström AK, Eyles D, Olsson T, Alfredsson L. Neonatal vitamin D status and risk of multiple sclerosis. Annals of Neurology 2014